USD 12.46
(-10.1%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 14.83 Million USD | -5.44% |
2022 | 15.68 Million USD | 1072.35% |
2021 | 1.33 Million USD | 1116.36% |
2020 | 110 Thousand USD | -30.38% |
2019 | 158 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 14.59 Million USD | -1.62% |
2024 Q2 | 14.32 Million USD | -1.8% |
2023 Q2 | 15.29 Million USD | -1.47% |
2023 Q4 | 14.83 Million USD | -1.56% |
2023 Q1 | 15.52 Million USD | -1.03% |
2023 FY | 14.83 Million USD | -5.44% |
2023 Q3 | 15.06 Million USD | -1.5% |
2022 Q2 | 16.99 Million USD | -1.7% |
2022 FY | 15.68 Million USD | 1072.35% |
2022 Q4 | 15.68 Million USD | -6.04% |
2022 Q1 | 17.28 Million USD | 1191.85% |
2022 Q3 | 16.69 Million USD | -1.75% |
2021 FY | 1.33 Million USD | 1116.36% |
2021 Q2 | 1.49 Million USD | -0.47% |
2021 Q3 | 1.51 Million USD | 1.07% |
2021 Q1 | 1.5 Million USD | 1265.45% |
2021 Q4 | 1.33 Million USD | -11.45% |
2020 FY | 110 Thousand USD | -30.38% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | 110 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 158 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 99.907% |
Allurion Technologies Inc. | 41.85 Million USD | 64.565% |
Artivion, Inc. | 359.34 Million USD | 95.872% |
Avanos Medical, Inc. | 209.1 Million USD | 92.907% |
Butterfly Network, Inc. | 25.02 Million USD | 40.736% |
Butterfly Network, Inc. | 25.02 Million USD | 40.736% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 98.945% |
Boston Scientific Corporation | 9.49 Billion USD | 99.844% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 98.504% |
Edwards Lifesciences Corporation | 694.9 Million USD | 97.866% |
Paragon 28, Inc. | 112.03 Million USD | 86.761% |
Glaukos Corporation | 383.73 Million USD | 96.135% |
Globus Medical, Inc. | 520.4 Million USD | 97.15% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 40.304% |
Integer Holdings Corporation | 1.04 Billion USD | 98.575% |
Medtronic plc | 26.04 Billion USD | 99.943% |
Nevro Corp. | 221.82 Million USD | 93.314% |
Owlet, Inc. | 15.21 Million USD | 2.524% |
Penumbra, Inc. | 234.34 Million USD | 93.671% |
Smith & Nephew plc | 3.08 Billion USD | 99.519% |
Sonendo, Inc. | 40.35 Million USD | 63.243% |
STERIS plc | 3.38 Billion USD | 99.562% |
Stryker Corporation | 12.99 Billion USD | 99.886% |
Vapotherm, Inc. | 112.39 Million USD | 86.803% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 99.753% |